Wird geladen...
Carisoprodol withdrawal syndrome resembling neuroleptic malignant syndrome: Diagnostic dilemma
Soma (Carisoprodol) is N-isopropyl-2 methyl-2-propyl-1,3-propanediol dicarbamate; a commonly prescribed, centrally acting skeletal muscle relaxant. Neuroleptic malignant syndrome (NMS) is a potentially life-threatening adverse effect of antipsychotic agents. Although diagnostic criteria for NMS have...
Gespeichert in:
| Veröffentlicht in: | J Anaesthesiol Clin Pharmacol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Medknow Publications & Media Pvt Ltd
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5009851/ https://ncbi.nlm.nih.gov/pubmed/27625493 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0970-9185.173346 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|